Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A ,MC1R and MITF-Reference-Cited by-同舟云学术

Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A ,MC1R and MITF

Published:2016-08-31 Issue:5 Volume:175 Page:1030-1037
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Mangas C.¹,Potrony M.²³,Mainetti C.¹,Bianchi E.⁴,Carrozza Merlani P.⁵,Mancarella Eberhardt A.⁶,Maspoli-Postizzi E.⁴,Marazza G.¹,Marcollo-Pini A.⁷,Pelloni F.⁴,Sessa C.⁸,Simona B.⁷,Puig-Butillé J.A.²³⁹,Badenas C.²³⁹,Puig S.²³

Affiliation:

1. Dermatologia Ente Ospedaliero Cantonale (EOC); Ospedale Regionale Bellinzona e Valli; Bellinzona Switzerland

2. Melanoma Unit; Hospital Clinic de Barcelona; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS); Universitat de Barcelona; Barcelona Spain

3. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER); ISCIII; Barcelona Spain

4. Private Dermatology Practice; Lugano Switzerland

5. Private Dermatology Practice; Bellinzona Switzerland

6. Private Dermatology Practice; Chiasso Switzerland

7. Private Dermatology Practice; Locarno Switzerland

8. Istituto Oncologico della Svizzera Italiana (IOSI); Ospedale Regionale Bellinzona e Valli; Bellinzona Switzerland

9. Biochemistry and Molecular Genetics Service; Hospital Clinic of Barcelona; Spain

Funder

Ospedale Regionale Bellinzona e Valli

Fondo de Investigaciones Sanitarias

Instituto de Salud Carlos III

Federación Española de Enfermedades Raras